Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Cephalalgia : an International Journal of Headache|September 21, 2019
Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adultsPeter J Goadsby, Stewart J Tepper, Paul B Watkins, et al.
Headache|October 27, 2018
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine TrackerDavid W Dodick, Stewart J Tepper, Richard B Lipton, et al.
Headache|September 6, 2016
Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 StudyStephen D Silberstein, Laszlo L Mechtler, David B Kudrow, et al.
Headache|September 22, 2021
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headacheMichael J Marmura, Hans-Christoph Diener, Robert P Cowan, et al.
Headache|August 7, 2021
Timing and durability of response to erenumab in patients with chronic migraineStewart J Tepper, Sylvia Lucas, Messoud Ashina, et al.
Neurology|September 20, 2022
Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative ReviewJessica Ailani, Eric A Kaiser, Paul G Mathew, et al.
Neurology|April 19, 2019
Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind studyRichard B Lipton, Stewart J Tepper, Uwe Reuter, et al.
Headache|June 14, 2023
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysisStewart J Tepper, Richard B Lipton, Stephen D Silberstein, et al.
Headache|March 16, 2013
Ictal adiponectin levels in episodic migraineurs: a randomized pilot trialB Lee Peterlin, Gretchen E Tietjen, Barbara A Gower, et al.
Headache|December 14, 2020
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2Hans-Christoph Diener, Michael J Marmura, Stewart J Tepper, et al.
Pageof 21